I. Epidémiologie and .. Economiques-de-la-maladie-de-chagas, 51 II.1 Epidémiologie de la maladie de Chagas, PARTIE, vol.2, p.52

R. Et-développement-de-vaccins and .. , 127 III.3.2.1 Vaccins à, ., p.133

T. Araujo-jorge, Part 1 Chapter 1 History of the discovery of american trypanosomiasis In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

J. Coura, Revista da Sociedade Brasileira de Medicina Tropical Discov Chagas Dis 1908-1909 Gt Successes Certain Misunderstandings Chall, août, vol.46, issue.4, 2013.
DOI : 10.1590/0037-8682-0143-2013

URL : http://doi.org/10.1590/0037-8682-0143-2013

D. Bargues and M. , Part 2 Chapter 6 Classification and Phylogeny of the Triatominae In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

C. Schofield and C. Galvao, Acta tropica. Classif Evol Species Groups Triatominae, mai, issue.110, 2009.

J. Jurberg and C. Galvao, Biology, ecology and systematics of Triatominae (Heteroptera, Reduviidae), vectors of Chagas disease, and implications for human health, 2006.

J. Dujardin, C. Schofield, and F. Panzera, Les vecteurs de la maladie de Chagas -Recherches taxonomiques, biologiques et génétiques, 2000.

F. Noireau and J. Dujardin, Part 2 Chapter In: American Trypanosomiasis Chagas disease -One hundred yeard of research, Biology of Triatominae, 2010.

M. Harry, Les Triatominae : des réduves démasqués, Insectes Santé, issue.80, 1991.

K. Tyler, C. Olson, and D. Engman, American Trypanosomiasis. The life cycle of Trypanosoma Cruzi, World Class Parasites. 2003 e éd, p.111, 2003.

D. Souza, W. , D. Carvalho, T. , S. Barrias et al., Part 4 Chapter 16 Ultrastructure of Trypanosoma cruzi and Its Interaction with Host Cells In: American Trypanosomiasis Chagas disease -One hundred years of research, 2010.

D. Teixeira, M. Benchimol, P. Crepaldi, D. Souza, and W. , Interactive Multimedia to Teach the Life Cycle of Trypanosoma cruzi, the Causative Agent of Chagas Disease, PLoS Neglected Tropical Diseases, vol.6, issue.8, pp.8-1749, 2012.
DOI : 10.1371/journal.pntd.0001749.g012

D. Lana, M. , M. Machado, and E. , Part 4 Chapter 14 Biology of Trypanosoma cruzi and Biological Diversity In: American Trypanosomiasis Chagas disease -One hundred years of research, 2010.

D. Bartholomeu, Part 4 Chapter 17 Genetics of Trypanosoma cruzi In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

A. Rassi, Part 7 Chapter 27 Clinical Phases and Forms of Chagas Disease In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

P. Aubry, Trypanosomiase humaine américaine (THAm) ou Maladie de Chagas, 2014.

F. Boissier, A. Nicoud, X. Duval, and D. Himbert, L'atteinte cardiaque de la maladie de Chagas. A propos d'une observation, Lett Cardiol. mars, issue.393, p.324, 2006.

P. Nunes and M. , Chagas Disease. An overview of clinical and epidemiological aspects, J Am Coll Cardiol, vol.62, issue.9, 2013.

R. Lecuyer, La maladie de Chagas en Argentine : une expérience en zone de transmission, 2012.

L. Loup, G. Ibrahim, K. Malvy, and D. , Maladie de Chagas et immunodépression : infection par le VIH et transplantation, Bull Soc Pathol Exot, vol.102, pp.310-318, 2009.

A. Rassi, A. Rassi, and J. Marin-neto, Chagas disease, Lancet. 17 avr, vol.375, issue.9723, p.1388402, 2010.

A. Teixeira, Pathogenesis os chagas' disease : parasite persistence and autoimmunity, Clin Microbiol Rev. juill, vol.24, issue.3, p.592630, 2011.
DOI : 10.1128/cmr.00063-10

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131057

S. Brenière, C. Aznar, and M. Hontebeyrie, Part 5 Chapter 21 Vector Transmission In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

Y. Carlier and C. Truyens, Part 5 Chapter 22 Maternal -Fetal Transmission of Trypanosoma cruzi In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

G. Schmunis, Prevention of transfusional Trypanosoma cruzi infection in Latin America, Mem??rias do Instituto Oswaldo Cruz, vol.811, issue.suppl 1, p.93101, 1999.
DOI : 10.1111/j.1423-0410.1993.tb02507.x

C. Bern, Chagas disease and the US blood supply, Current Opinion in Infectious Diseases, vol.21, issue.5, p.47682, 2008.
DOI : 10.1097/QCO.0b013e32830ef5b6

Q. Liu and X. Zhou, Preventing the transmission of American trypanosomiasis and its spread into nonendemic countries, Infect Dis Poverty, vol.4, issue.60, 2015.

M. Shikanai-yasuda, B. Carvalho, and N. , Oral Transmission of Chagas Disease, Clinical Infectious Diseases, vol.54, issue.6, p.84552, 2012.
DOI : 10.1093/cid/cir956

A. Luquetti and G. Schmunis, Part 7 Chapter 28 Diagnosis of Trypanosoma cruzi Infection In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

J. Pays, Le diagnostic biologique de la maladie de Chagas. Rev Francoph Lab, mars, issue.430, p.4759, 2011.
DOI : 10.1016/s1773-035x(11)70825-5

R. Curtis-robles, Epidemiology and Molecular Typing of Trypanosoma cruzi in Naturally-Infected Hound Dogs and Associated Triatomine Vectors in Texas, USA, PLOS Neglected Tropical Diseases, vol.223, issue.1, 2017.
DOI : 10.1371/journal.pntd.0005298.t006

D. Jeannel, B. Pelletier, J. Pillonel, and A. Assal, Maladie de Chagas et risque transfusionnel en France. InVS, 2007.

C. Schofield, Triatomes du vieux monde et possibilites de transmission vectorielle de la maladie de Chagas, 2008.

J. Patterson and F. Guhl, Part 1 Chapter 5 Geographical Distribution of Chagas Disease In: American Trypanosomiasis Chagas disease -One hundred years of research, 2010.

. Invs, Surveiller l'émergence de la maladie de Chagas en Guyane. Lett Institur Veille Sanit, Avril, issue.15, 2006.

D. Salamanca-dejour, La maladie de Chagas (ou trypanosomose am??ricaine) en France, M??decine et Maladies Infectieuses, vol.42, issue.8, p.3448, 2012.
DOI : 10.1016/j.medmal.2011.01.006

. Invs, Emergence de la maladie de Chagas en Guyane française. Evaluation en 2005 et perspectives, 2007.

G. De-jesus, Les aspects économiques de la schistosomiase et de la maladie de Chagas au Brésil, 1982.

W. Maladie-de-chagas, Progrès réalisés vers l'élimination de la transmission. Relevé Épidémiologique Hebd, 12 janv, issue.2, 1996.

M. Castillo-riquelme and F. Guhl, The Costs of Preventing and Treating Chagas Disease in Colombia, PLoS Neglected Tropical Diseases, vol.46, issue.4, 2008.
DOI : 10.1371/journal.pntd.0000336.s001

A. Moncayo and A. Silveira, Part1 Chapter 4 Current trends and future prospects for control of Chagas disease In: American trypanosomiasis Chagas disease -One hundred years of research

D. Gorla, Part2 Chapter 10 Control strategies against triatominae In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

C. Schofield, J. Jannin, and R. Salvatella, The future of Chagas disease control, Trends in Parasitology, vol.22, issue.12, p.5838, 2006.
DOI : 10.1016/j.pt.2006.09.011

. Organisation-panaméricaine-de-la-santé, Stratégie et plan d'action pour la prévention, le contrôle et les sins contre la malade de Chagas, 2010.

V. Yevstigneyeva, J. Camara-mejia, and E. Dumonteil, Analysis of Children's Perception of Triatomine Vectors of Chagas Disease through Drawings: Opportunities for Targeted Health Education, PLoS Neglected Tropical Diseases, vol.26, issue.1, 2014.
DOI : 10.1371/journal.pntd.0003217.s003

J. Rozendaal, Traitement des habitations au moyen d'insecticides à effet rémanent, La lutte antivectorielle Méthodes à usage individuel et communautaire, p.390420, 1999.

E. Zerba, Susceptibility and resistance to insecticides of Chagas disease vectors, Med B Aires, issue.59, p.416, 1999.

G. Marti, Prevalence and distribution of parasites and pathogens of Triatominae from Argentina, with emphasis on Triatoma infestans and Triatoma virus TrV, Journal of Invertebrate Pathology, vol.102, issue.3, 2009.
DOI : 10.1016/j.jip.2009.06.010

G. Marti, Isolation of Beauveria bassiana (Bals.) Vuill. (Deuteromycotina: Hyphomycetes) from the Chagas disease vector, Triatoma infestans (Hemiptera: Reduviidae) in Argentina, Mycopathologia, vol.24, issue.4, 2005.
DOI : 10.1007/s11046-005-9499-1

M. Susevich, New Triatoma virus hosts in wild habitats of Argentina, Journal of Invertebrate Pathology, vol.110, issue.3, p.4057, 2012.
DOI : 10.1016/j.jip.2012.03.023

A. Wolf, Le nifurtimox, molécule en plein devenir dans le traitement de la maladie de Chagas, Med Trop (Mars), issue.72, p.1313, 2011.

C. Coilliot and A. Wolf, Le benznidazole un des rares traitements de la maladie de Chagas, Med Trop (Mars), issue.71, p.3412, 2011.

M. Develoux, L. Loup, G. Pialoux, and G. , La maladie de Chagas : une parasitose latino-américaine émergente en dehors de ses zones d'endémie, Lett Infect. oct, issue.5, p.1726, 2013.
DOI : 10.1016/j.antinf.2012.01.003

G. Benaim, Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole, J Med Chem. 9 févr, vol.3, issue.49, p.8929, 2006.
DOI : 10.1021/jm050691f

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.561.6944

R. Dantas, Effect of nifedipine on the lower esophageal spincter pressure in chagasic patients, Bazilian J Med Biol Res, vol.2, p.2059, 1986.

E. Chatelain, Chagas Disease Drug Discovery, Journal of Biomolecular Screening, vol.14, issue.1, 2014.
DOI : 10.1186/1471-2334-14-302

J. Bermudez, Current drug therapy and pharmaceutical challenges for Chagas disease, Acta Tropica, vol.156, issue.156, p.116, 2016.
DOI : 10.1016/j.actatropica.2015.12.017

W. Apt, Part7 Chapter 30 Treatment of Chagas disease In: American trypanosomiasis Chagas disease -One hundred years of research, 2010.

. Collège-natinal-de-pharmacologie-médicale, Antifongiques : les points essentiels, 2017.

W. Apt, Treatment of Chagas' disease with itraconazole: electrocardiographic and parasitological conditions after 20 years of follow-up, Journal of Antimicrobial Chemotherapy, vol.68, issue.9, p.21649, 2013.
DOI : 10.1093/jac/dkt135

E. Chatelain and K. Nandini, Translational challenges of animal models in Chagas disease drug development: a review, Drug Design, Development and Therapy, issue.9, p.480723, 2015.
DOI : 10.2147/DDDT.S90208

M. Keenan and J. Chaplin, A New Era for Chagas Disease Drug Discovery?, Prog Med Chem, issue.54, p.185230, 2015.
DOI : 10.1016/bs.pmch.2014.12.001

I. Molina, Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease, New England Journal of Medicine, vol.370, issue.20, p.1899908, 2014.
DOI : 10.1056/NEJMoa1313122

E. Chatelain, Chagas disease research and development: Is there light at the end of the tunnel?, Computational and Structural Biotechnology Journal, vol.15, issue.15, p.98103, 2017.
DOI : 10.1016/j.csbj.2016.12.002

G. Lepesheva, Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?, Expert Opinion on Drug Discovery, vol.47, issue.12, p.147989, 2013.
DOI : 10.1021/jm2015809

V. Duschak, Targets and patented drugs for chemotherapy of Chagas disease in the last 15 years-period. Recent Patents Anti-Infect Drug Disc, p.74173, 2016.

D. Lowe, Three diseases at once? blog.sciencemag.org, 2016.

B. Miller and A. Roitberg, -sialidase as a drug target against Chagas disease (American trypanosomiasis), Future Medicinal Chemistry, vol.5, issue.15, p.1889900, 2013.
DOI : 10.4155/fmc.13.129

URL : https://hal.archives-ouvertes.fr/hal-00901459

P. Doyle, The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion, PLoS Pathogens, vol.280, issue.9, 2011.
DOI : 10.1371/journal.ppat.1002139.g008

URL : http://doi.org/10.1371/journal.ppat.1002139

K. Rogers, Novel Cruzain Inhibitors for the Treatment of Chagas??? Disease, Chemical Biology & Drug Design, vol.53, issue.8, p.398405, 2012.
DOI : 10.1021/ci010025x

A. Fourmet, Du nouveau dans le traitement de la maladie de Chagas : la canthin-6-one

J. Dai, Fruitful decades for canthin-6ones from 1952 to 2015 : Biosynthesis, chemistry and biological activities. molecules, p.493
DOI : 10.3390/molecules21040493

URL : http://doi.org/10.3390/molecules21040493

A. Padilla, C. Perez-brandan, and M. Basombrio, Part7 Chapter 31 Vaccine development for Chagas disease In: American trypanosomiasis Chagas disease -One hundred years of research

C. Leclerc, L???apport des nouvelles technologies en vaccinologie, m??decine/sciences, vol.23, issue.4, p.38690, 2007.
DOI : 10.1051/medsci/2007234386

S. Hantz, A. S. Denis, and F. , Vaccins thérapeutiques ciblant les lésions précancéreuses à papillomavirus, Virologie, vol.3, issue.15, p.17591, 2011.

G. Sanchez-burgos, Comparative efficacy of DNA vaccines encoding various Trypanosoma cruzi antigens, FEMS Microbio Med Immunol. août, vol.3, issue.50, p.33341, 2007.

E. Dumonteil, Essai clinique d'un vaccin thérapeutique contre la maladie de Chagas chez le chien. Rapport technique final. Httpwwwimeafrimeafichiersjointsimea-Proj-Soutenus0603-Rapp-Final, déc, 2008.

I. Quinajo-hernandez and A. Castro-barcena, Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi, Vaccine. 26 avr, vol.18, issue.31, p.224652, 2013.

E. Dumonteil and I. Quinajo-hernandez, Advances and challenges towards a vaccine against Chagas disease, Hum Vaccin. 1 nov, vol.11, issue.7, p.118491, 2011.

E. Dumonteil and M. Botazzi, Accelerating the development of a therapeutic vaccine for human chagas disease, Expert Rev Vaccines, vol.9, issue.11, p.104355, 2012.